Data / Form D filings / Amlogenyx Inc.
Amlogenyx Inc.: Form D filings
Amlogenyx Inc., a biotechnology company in Novato, CA, filed 2 Form D notices with the SEC between 2024 and 2026. The latest, on July 9, 2026, reports $10 million sold of a $20 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 77 DIGITAL DRIVE, SUITE 200, Novato, CA, 94949
- Phone
- (415) 483-8800
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2031988
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | New notice | $20,000,000 | $10,000,000 | $10,000,000 | 2 | Jul 1, 2026 | sec.gov |
| Aug 2, 2024 | New notice | $13,999,989 | $13,999,989 | 4 | Jul 26, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| TED HUIZENGA | Executive Officer | |
| JOHN PINION | Executive Officer | |
| CRAIG GORDON | Director | |
| EMIL KAKKIS | Executive Officer, Director | |
| SUKUMAR NAGENDRAN | Director | |
| Karah Parschauer | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jul 6, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Amlogenyx Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.